Exploring the Aggregation Propensity of PHF6 Peptide Segments of the Tau Protein Using Ion Mobility Mass Spectrometry Techniques.
Iuliia StroganovaHannah WillenbergThaleia TenteAgathe Depraz DeplandSjors BakelsAnouk M RijsPublished in: Analytical chemistry (2024)
Peptide and protein aggregation involves the formation of oligomeric species, but the complex interplay between oligomers of different conformations and sizes complicates their structural elucidation. Using ion mobility mass spectrometry (IM-MS), we aim to reveal these early steps of aggregation for the Ac-PHF6-NH 2 peptide segment from tau protein, thereby distinguishing between different oligomeric species and gaining an understanding of the aggregation pathway. An important factor that is often neglected, but which can alter the aggregation propensity of peptides, is the terminal capping groups. Here, we demonstrate the use of IM-MS to probe the early stages of aggregate formation of Ac-PHF6-NH 2 , Ac-PHF6, PHF6-NH 2 , and uncapped PHF6 peptide segments. The aggregation propensity of the four PHF6 segments is confirmed using thioflavin T fluorescence assays and transmission electron microscopy. A novel approach based on post-IM fragmentation and quadrupole selection on the TIMS-Qq-ToF (trapped ion mobility) spectrometer was developed to enhance oligomer assignment, especially for the higher-order aggregates. This approach pushes the limits of IM identification of isobaric species, whose signatures appear closer to each other with increasing oligomer size, and provides new insights into the interpretation of IM-MS data. In addition, TIMS collision cross section values are compared with traveling wave ion mobility (TWIMS) data to evaluate potential instrumental bias in the trapped ion mobility results. The two IM-MS instrumental platforms are based on different ion mobility principles and have different configurations, thereby providing us with valuable insight into the preservation of weakly bound biomolecular complexes such as peptide aggregates.
Keyphrases
- mass spectrometry
- liquid chromatography
- high resolution
- gas chromatography
- high performance liquid chromatography
- capillary electrophoresis
- ms ms
- multiple sclerosis
- amino acid
- protein protein
- electronic health record
- big data
- electron microscopy
- binding protein
- cerebrospinal fluid
- dna methylation
- risk assessment
- machine learning
- gene expression
- high throughput
- genome wide
- artificial intelligence
- single molecule
- living cells
- simultaneous determination
- solid phase extraction
- fluorescent probe